The variant affects gene FGFR2 (fibroblast growth factor receptor 2), which is on Chromosome 10. Please evaluate whether this mutation is benign or pathogenic and specify the disease if necessary.
Pathogenic; FGFR2-related syndromic and non-syndromic craniosynostoses